Archive for January 2008
Randomized, Controlled Multicenter Trial Demonstrates Safety and Clinical Benefit, Significant Reduction in Repeat Surgeries Enabled by Dune’s MarginProbe®
[vc_row][vc_column][vc_column_text]Company Opens US Office to Spearhead North American Operations Caesarea, Israel-Jan. 7, 2008 – Dilon Devices announces significant new clinical developments surrounding the company’s novel breast cancer assessment probe, currently in investigational use. Results from a recent randomized clinical trial in 11 medical centers in Israel have underscored the safety and clinical benefit of the…
Read MorePredictors of Re-Excision Among Women Undergoing Breast-Conserving Surgery for Cancer
[vc_row][vc_column][vc_column_text]Waljee JF, et al. Ann Surg Oncol. 2008;15(5):1297-1303. View Study[/vc_column_text][/vc_column][/vc_row]
Read MoreMargins in Breast-Conserving Therapy: Have We Lost Sight of the Big Picture?
[vc_row][vc_column][vc_column_text]Morrow M. Expert Rev Anticancer Ther. 2008;8(8):1193-1196. View Study [/vc_column_text][/vc_column][/vc_row]
Read MoreA Prospective, Randomized, Controlled, Multicenter Study of a Real-Time, Intraoperative Probe for Positive Margin Detection in Breast-Conserving Surgery.
[vc_row][vc_column][vc_column_text]View Study[/vc_column_text][/vc_column][/vc_row]
Read More